查詢結果分析
相關文獻
- Eradication of Hepatitis C Virus Preserve Liver Function and Prolong Survival in Advanced Hepatocellular Carcinoma Patients with Limited Life Expectancy
- 人格同一與存活
- 臨床研究最重要的統計分析方法:存活分析(Survival analysis)
- Sorafenib (Nexavar®)--臺灣第一個晚期肝癌治療藥物
- Sorafenib (Nexavar®)--治療腎細胞癌又見新藥
- Second Primary Oral Cancers after Curative Surgery
- Experience of Sorafenib Treatment in Differentiated Thyroid Cancer from Taiwan
- Chronic Obstructive Pulmonary Disease as a Risk Factor of Alzheimer's Disease among Elderly Population in Taiwan: A Population-based Retrospective Cohort Study
- A Long-term Treatment Outcome of Intentional Replantation in Taiwanese Population
- Associations of Thoracic Cage Size and Configuration with Outcomes of Adult In-hospital Cardiac Arrest: A Retrospective Cohort Study
頁籤選單縮合
題名 | Eradication of Hepatitis C Virus Preserve Liver Function and Prolong Survival in Advanced Hepatocellular Carcinoma Patients with Limited Life Expectancy |
---|---|
作者姓名(中文) | Yeh, Ming-lun; Kuo, Hsing-tao; Huang, Ching-i; Huang, Chung-feng; Hsieh, Ming-yen; Liang, Po-cheng; Lin, I-hung; Hsieh, Meng-hsuan; Lin, Zu-yau; Chen, Shinn-chern; Dai, Chia-yen; Huang, Jee-fu; Yu, Ming-lung; Chuang, Wan-long; | 書刊名 | The Kaohsiung Journal of Medical Sciences |
卷期 | 37:2 2021.02[民110.02] |
頁次 | 頁145-153 |
分類號 | 415.5362 |
關鍵詞 | Direct acting antivirals; Hepatitis C virus; Hepatocellular carcinoma; Sorafenib; Survival; |
語文 | 英文(English) |